A Study to See if an Energy Drink With Caffeine and Green Tea Increases Fat Burning When Exercising

NCT07434752 — Phase 4, Active not recruiting, 36 participants, RDC Clinical Pty Ltd

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Influence of Caffeine and Green Tea Extracts Consumption on Basal, Peri- and Post-exercise Fat Oxidation

RegistryNCT07434752
StatusActive not recruiting
PhasePhase 4
Study typeInterventional; randomized, crossover, masking: quadruple, treatment
Enrollment36 (Actual)
SponsorRDC Clinical Pty Ltd (Industry); collaborators: Amway Corp
ConditionsExercise
InterventionsActive (Green tea and caffeine), Placebo (Dietary supplement, other)
Datesstart 2026-03-26, primary completion 2026-09-18 (estimated), completion 2026-09-18 (estimated), first posted 2026-02-27, last updated 2026-09-09
Locations1 site in Australia

Related Papers Related Patents Related Grants Related Experts
All trials for Exercise All trials of Active (Green tea and caffeine) All trials of Placebo

-Summary

The goal of this study is to evaluate the influence of consuming a drink containing a combination of caffeine and green tea extracts on fat oxidation responses at rest, during and after a period of endurance type exercise.

Expand all sections  ·  Collapse all

+Detailed description

This study investigates whether consuming an energy drink containing caffeine and green tea extract before exercise increases fat burning (oxidation) compared with a placebo drink. Healthy, moderately active adults will attend three visits at clinic over 3-5 weeks. The first visit determines each participant's individual exercise intensity that maximises fat use during cycling. At two subsequent visits, participants will consume either the active drink or a placebo before completing a 30-minute cycling session at their personalised intensity. Fat and carbohydrate use, heart rate, blood pressure, and subjective responses will be measured at rest, during exercise, and after exercise using a double-blind, crossover design.

+Arms and interventions

ArmTypeInterventionsDescription
ActiveExperimentalDietary Supplement: Active (Green tea and caffeine)Two 355 mL cans of "XS Energy + BURN" drink containing caffeine and green tea extract.
PlaceboOtherOther: PlaceboTwo 355 mL cans of placebo drink but without the active ingredients (caffeine and green tea extract).
  • Active (Green tea and caffeine) (Dietary supplement), also known as XS Energy + BURN: Two 355 mL cans of "XS Energy + BURN" drink containing caffeine and green tea extract.
  • Placebo (Other): Two 355 mL cans of placebo drink but without the active ingredients (caffeine and green tea extract).

+Outcome measures

Primary outcomes

  • Fat oxidation as measured by indirect calorimetry [Baseline to 30 mins post exercise]: Change from baseline to the end of the study period in Fat oxidation as measured by indirect calorimetry (metabolic cart); baseline (pre-drink), post-drink (pre-exercise), time sequence e.g., every 5-min during exercise, 10, 20 and 30-min post-exercise. Change from baseline \& total. Fat oxidation will be measured continuously throughout the exercise and the 30-min post-exercise window, to facilitate total, and any other temporal fat oxidation timepoints.

Secondary outcomes

  • Carbohydrate oxidation; indirect calorimetry [Baseline to 30 mins post exercise]: Change from baseline to the end of the study period in Carbohydrate oxidation; indirect calorimetry; same timing as fat oxidation (baseline (pre-drink), post-drink (pre-exercise), time sequence e.g., every 5-min during exercise, 10, 20 and 30-min post-exercise.). Change from baseline \& total.
  • Respiratory exchange ratio; indirect calorimetry [Baseline to 30 mins post exercise]: Change from baseline to the end of the study period in Respiratory exchange ratio; indirect calorimetry; same timing as fat oxidation (baseline (pre-drink), post-drink (pre-exercise), time sequence e.g., every 5-min during exercise, 10, 20 and 30-min post-exercise). Change from baseline \& total
  • Exercise efficiency; indirect calorimetry [Baseline to 30 mins post exercise]: Change from baseline to the end of the study period in Exercise efficiency; indirect calorimetry; time sequence during exercise e.g., every 5-min. Change from the beginning of exercise \& average

Other outcomes

  • Tertiary: Compliance monitoring [Baseline to end of study period (week 5)]: Compliance monitoring for adherence to clinical trial components e.g. consumed volume of investigational product; ability to complete the necessary duration (30 mins) and intensity (at fat max) of exercise; adherence to immediate pre-trial control procedures of no caffeine or green tea extract in the 12 hours leading up to the experimental, arrival at the laboratory after an overnight fast
  • Tertiary: Adverse Event monitoring [Baseline to end of study period (week 5)]: Adverse events will be monitored throughout the study across the study periods.
  • Tertiary: Perceived gastrointestinal (dis)comfort questionnaire [Baseline to end of study (week 5)]: Change from baseline to the end of the study period in Perceived gastrointestinal (dis)comfort; measured via a questionnaire.
  • Tertiary: Perceived satiety / hunger [Baseline to end of study period (week 5)]: Change from baseline to the end of the study period in Perceived satiety / hunger; measured via questionnaire.
  • Tertiary: Perceived exercising exertion [Baseline to end of study period (week 5)]: Change from baseline to the end of the study period in Perceived exercising exertion; measured via questionnaire.
  • Tertiary: heart rate [Baseline to end of study period (week 5)]: Change from baseline to the end of the study period in heart rate. Pre, during and post exercise heart rate.
  • Tertiary: blood pressure [Baseline to end of study period (week 5)]: Change from baseline to the end of the study period in blood pressure. Pre, during and post exercise blood pressure.
  • Tertiary: Safety via AE monitoring [Baseline to end of study period (week 5)]: Change from baseline to the end of the study period in safety via AE monitoring.
  • Tertiary: Anthropometry - BMI [Baseline to end of study period (week 5)]: Change from baseline to the end of the study period in BMI.
  • Tertiary: Anthropometry - weight [Baseline to end of study period (week 5)]: Change from baseline to the end of the study period in weight.
  • Tertiary: Anthropometry - waist circumference [Baseline to end of study period (week 5)]: Change from baseline to the end of the study period in waist circumference.

+Eligibility

Sex: All, ages: 18 Years to 45 Years, accepts healthy volunteers

Inclusion Criteria:

* Passing the Exercise and Sport Science Australia adult pre-exercise screening system (APSS) stage 1 \& 2 (see appendix 4).
* Between the ages of 18 and 45,
* Not sedentary, and not completing more than 150 minutes of low and/or moderate and/or or vigorous intensity endurance exercise a week,
* Ability to commit to in principle fulfilment of all 3 trial visits,
* No history of coagulopathy e.g., DVT, stroke,
* No known heart disease,
* No known pancreatic insufficiency,
* No known inflammatory bowel disease, or prior bowel resection or bypass surgery (excluding gastric banding and sleeve),
* BMI of 22.0 to 34.9 kg/m2,
* No known allergies to caffeine or green tea extract,
* No known type I or II diabetes,
* No uncontrolled concurrent illness,
* No known current pregnancy or breastfeeding women
* No current regular consumption of supplements (>2 times a week) or foods and drinks containing caffeine and/or green tea extracts (>2 times per day, weekly).
* Agree not to consume caffeine for 12-hours prior to the clinic visit.

Exclusion Criteria:

* Triggering any of the exclusion screening criteria as outlined below, and in compliment with the Exercise and Sport Science Australia adult pre-exercise screening system (APSS).
* Under the age of 18 or over the age of 45,
* Sedentary, or completing over 150 minutes of low and/or moderate and/or or vigorous intensity endurance exercise a week,
* Inability to commit to in principle fulfilment of all 3 trial visits,
* History of coagulopathy e.g., DVT, stroke,
* Known heart disease,
* Known pancreatic insufficiency,
* Known inflammatory bowel disease, or prior bowel resection or bypass surgery (excluding gastric banding and sleeve),
* BMI < 22.0 or > 34.9 kg/m2,
* Known allergies to caffeine or green tea extract,
* Known type I or II diabetes,
* Uncontrolled concurrent illness,
* Taking GLP-1 agonists, caffeine, or any other medication known to affect metabolism.
* Known current pregnancy or breastfeeding women.
* Currently regularly consuming supplements, foods or drinks containing a caffeine and green tea extract blend, or not willing to abstain for the study

+Locations (1)

FacilityCityCountryStatus
Griffith University, Gold Coast CampusSouthport, QueenslandAustralia